ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Introduction

Lecture Time
11:45 - 11:50
Speakers
  • D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Conclusion

Lecture Time
13:10 - 13:15
Speakers
  • D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Are immune checkpoints (ICPs) better as single agent, doublet ICPs or combined with chemo +/- anti-angiogenics?

Lecture Time
12:30 - 12:50
Speakers
  • S. Peters (Lausanne, Switzerland)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • S. Peters (Lausanne, Switzerland)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

First-line immunotherapy options for patients without an oncogene driver

Lecture Time
11:50 - 12:10
Speakers
  • R. Califano (Manchester, United Kingdom)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • R. Califano (Manchester, United Kingdom)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Recommendation on second-line treatment according to first-line choice

Lecture Time
12:50 - 13:10
Speakers
  • D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

What is the biological rationale for combining chemotherapy with immune checkpoint inhibitors?

Lecture Time
12:10 - 12:30
Speakers
  • M. Garassino (Milan, Italy)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • M. Garassino (Milan, Italy)
Opening and welcome Opening and welcome

Welcome to the Congress

Lecture Time
13:30 - 13:35
Speakers
  • P. Garrido Lopez (Madrid, Spain)
  • J. Wolf (Cologne, Germany)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
13:30 - 13:45
Authors
  • P. Garrido Lopez (Madrid, Spain)
  • J. Wolf (Cologne, Germany)
Opening and welcome Opening and welcome

Introduction to IASLC

Lecture Time
13:35 - 13:40
Speakers
  • G. Scagliotti (Orbassano, TO, Italy)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
13:30 - 13:45
Authors
  • G. Scagliotti (Orbassano, TO, Italy)
Opening and welcome Opening and welcome

Introduction to ESMO

Lecture Time
13:40 - 13:45
Speakers
  • S. Peters (Lausanne, Switzerland)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
13:30 - 13:45
Authors
  • S. Peters (Lausanne, Switzerland)
HHH Award lecture Keynote Lecture

The HHH model applied to radiotherapy: Honour the past, evaluate the present and stimulate the future

Lecture Time
13:45 - 14:15
Speakers
  • F. Mornex (Pierre Bénite, France)
Session Name
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
13:45 - 14:15
Authors
  • F. Mornex (Pierre Bénite, France)
Early detection, screening, prevention Educational session

Q&A

Lecture Time
15:21 - 15:24
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
My patient has stage IIIA (N2) disease: Surgery or radiotherapy? Multidisciplinary Tumour Board

My patient needs surgery upfront followed by adjuvant treatment

Lecture Time
15:07 - 15:34
Speakers
  • M. Pless (Winterthur, Switzerland)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • M. Pless (Winterthur, Switzerland)